{"title":"Survival Following Primary Androgen Deprivation Therapy Among Men With Localized Prostate Cancer","authors":"J. Zabell","doi":"10.1093/MED/9780190655341.003.0012","DOIUrl":null,"url":null,"abstract":"This chapter summarizes the findings of a population-based, observational study comparing men with clinically localized prostate cancer who received primary androgen-deprivation therapy (ADT) or were treated conservatively. The investigator used instrumental variable analysis to adjust for potential confounders. This study found no improvement in survival for men receiving primary ADT.","PeriodicalId":435097,"journal":{"name":"50 Studies Every Urologist Should Know","volume":"17 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"50 Studies Every Urologist Should Know","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/MED/9780190655341.003.0012","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
This chapter summarizes the findings of a population-based, observational study comparing men with clinically localized prostate cancer who received primary androgen-deprivation therapy (ADT) or were treated conservatively. The investigator used instrumental variable analysis to adjust for potential confounders. This study found no improvement in survival for men receiving primary ADT.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
